| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue, Brown | 7 | 2021 | 39 | 3.110 |
Why?
|
| Follistatin | 6 | 2021 | 27 | 2.300 |
Why?
|
| Breast Neoplasms | 13 | 2020 | 1426 | 2.090 |
Why?
|
| Nitric Oxide | 7 | 2016 | 287 | 1.540 |
Why?
|
| Nitroso Compounds | 4 | 2016 | 11 | 1.140 |
Why?
|
| Neoplastic Stem Cells | 5 | 2020 | 74 | 1.110 |
Why?
|
| Myostatin | 3 | 2021 | 57 | 1.050 |
Why?
|
| Obesity | 4 | 2021 | 965 | 1.030 |
Why?
|
| Apoptosis | 8 | 2016 | 1317 | 0.910 |
Why?
|
| Health | 1 | 2021 | 28 | 0.820 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 242 | 0.780 |
Why?
|
| Adipose Tissue, White | 2 | 2017 | 13 | 0.780 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 32 | 0.780 |
Why?
|
| Cell Differentiation | 5 | 2017 | 562 | 0.770 |
Why?
|
| Animal Feed | 1 | 2020 | 42 | 0.770 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 91 | 0.750 |
Why?
|
| Transforming Growth Factor beta | 3 | 2017 | 183 | 0.730 |
Why?
|
| Mitochondria | 4 | 2016 | 454 | 0.700 |
Why?
|
| Cell Line, Tumor | 10 | 2020 | 2128 | 0.700 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 137 | 0.690 |
Why?
|
| Nicotine | 1 | 2020 | 238 | 0.650 |
Why?
|
| Nitric Oxide Donors | 3 | 2016 | 18 | 0.630 |
Why?
|
| Adipocytes, White | 1 | 2017 | 3 | 0.620 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 8 | 0.620 |
Why?
|
| Signal Transduction | 7 | 2021 | 1802 | 0.620 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 8 | 0.610 |
Why?
|
| Animals | 16 | 2021 | 14307 | 0.560 |
Why?
|
| Mice | 12 | 2021 | 5668 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 139 | 0.550 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 107 | 0.520 |
Why?
|
| Arginase | 1 | 2013 | 12 | 0.480 |
Why?
|
| Down-Regulation | 2 | 2013 | 420 | 0.480 |
Why?
|
| Plant Extracts | 1 | 2016 | 250 | 0.470 |
Why?
|
| Energy Metabolism | 4 | 2021 | 160 | 0.460 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 28 | 0.450 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 39 | 0.440 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1149 | 0.440 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 59 | 0.430 |
Why?
|
| Up-Regulation | 5 | 2020 | 490 | 0.420 |
Why?
|
| Oxidative Stress | 3 | 2020 | 874 | 0.410 |
Why?
|
| Female | 15 | 2021 | 19873 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 94 | 0.410 |
Why?
|
| Proteomics | 1 | 2013 | 302 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 209 | 0.390 |
Why?
|
| Vitamin D | 1 | 2013 | 176 | 0.390 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 69 | 0.390 |
Why?
|
| Humans | 18 | 2021 | 34853 | 0.390 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 123 | 0.380 |
Why?
|
| Thermogenesis | 3 | 2021 | 20 | 0.380 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 146 | 0.370 |
Why?
|
| Mice, Nude | 3 | 2016 | 323 | 0.350 |
Why?
|
| Fibronectins | 2 | 2021 | 65 | 0.350 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 600 | 0.340 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 114 | 0.330 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 18 | 0.330 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2007 | 14 | 0.300 |
Why?
|
| Protein Kinases | 1 | 2007 | 91 | 0.290 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 220 | 0.270 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 96 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 229 | 0.260 |
Why?
|
| Arginine | 3 | 2013 | 62 | 0.250 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 13 | 0.240 |
Why?
|
| Hydrazines | 1 | 2003 | 21 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 97 | 0.240 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 42 | 0.240 |
Why?
|
| Immediate-Early Proteins | 1 | 2003 | 45 | 0.240 |
Why?
|
| Cells, Cultured | 5 | 2017 | 1442 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 122 | 0.230 |
Why?
|
| Follistatin-Related Proteins | 1 | 2021 | 2 | 0.200 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2016 | 72 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 968 | 0.200 |
Why?
|
| Mecamylamine | 1 | 2020 | 14 | 0.200 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 30 | 0.190 |
Why?
|
| Immunoblotting | 3 | 2016 | 170 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 93 | 0.190 |
Why?
|
| Imidazoles | 1 | 2020 | 124 | 0.190 |
Why?
|
| Pyridines | 1 | 2020 | 113 | 0.190 |
Why?
|
| Muscle Development | 2 | 2011 | 44 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2021 | 213 | 0.180 |
Why?
|
| Ligands | 1 | 2021 | 317 | 0.180 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 152 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2013 | 834 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 245 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 4 | 2017 | 1530 | 0.160 |
Why?
|
| Ion Channels | 2 | 2015 | 69 | 0.160 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 20 | 0.160 |
Why?
|
| Cyclic GMP | 2 | 2008 | 44 | 0.160 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 14 | 0.150 |
Why?
|
| Multigene Family | 1 | 2017 | 105 | 0.150 |
Why?
|
| Models, Animal | 1 | 2017 | 131 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 608 | 0.150 |
Why?
|
| Retinal Dehydrogenase | 1 | 2016 | 11 | 0.150 |
Why?
|
| Exercise | 1 | 2021 | 524 | 0.140 |
Why?
|
| Vernonia | 1 | 2016 | 15 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 386 | 0.140 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 71 | 0.140 |
Why?
|
| Inflammation | 1 | 2020 | 577 | 0.140 |
Why?
|
| Isoenzymes | 1 | 2016 | 149 | 0.140 |
Why?
|
| Caspase 3 | 1 | 2016 | 194 | 0.140 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 149 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2011 | 878 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 605 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2015 | 80 | 0.130 |
Why?
|
| Male | 7 | 2021 | 18870 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2015 | 75 | 0.130 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2013 | 2 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 416 | 0.120 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 87 | 0.120 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 79 | 0.120 |
Why?
|
| Adipocytes | 1 | 2014 | 54 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2013 | 79 | 0.120 |
Why?
|
| Cytochrome c Group | 2 | 2003 | 13 | 0.120 |
Why?
|
| Retinoid X Receptors | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cell Separation | 1 | 2013 | 91 | 0.110 |
Why?
|
| RNA Interference | 1 | 2013 | 225 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 255 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 89 | 0.110 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2011 | 8 | 0.110 |
Why?
|
| Receptors, Androgen | 2 | 2011 | 122 | 0.100 |
Why?
|
| Protein Stability | 1 | 2011 | 40 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 126 | 0.100 |
Why?
|
| Macromolecular Substances | 1 | 2011 | 86 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2011 | 54 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2013 | 653 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 178 | 0.100 |
Why?
|
| Testosterone | 1 | 2011 | 181 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2008 | 309 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 184 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 391 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 103 | 0.090 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2008 | 11 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 21 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2008 | 20 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2008 | 14 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 40 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 46 | 0.080 |
Why?
|
| Genes, ras | 1 | 2008 | 22 | 0.080 |
Why?
|
| Oxidants | 1 | 2008 | 43 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 87 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 65 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2011 | 366 | 0.080 |
Why?
|
| Heme | 1 | 2008 | 69 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 580 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 181 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 781 | 0.080 |
Why?
|
| raf Kinases | 1 | 2007 | 6 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2008 | 423 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 41 | 0.080 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2007 | 14 | 0.080 |
Why?
|
| Breast | 1 | 2008 | 134 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 166 | 0.070 |
Why?
|
| Intracellular Membranes | 2 | 2003 | 34 | 0.070 |
Why?
|
| Membrane Potentials | 2 | 2003 | 213 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 480 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 162 | 0.070 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2003 | 6 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2003 | 48 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 984 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 38 | 0.060 |
Why?
|
| Cytosol | 1 | 2003 | 85 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2003 | 58 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2014 | 109 | 0.060 |
Why?
|
| Caspases | 1 | 2002 | 132 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2014 | 897 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 257 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 287 | 0.050 |
Why?
|
| Middle Aged | 1 | 2013 | 9642 | 0.040 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2014 | 6 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2014 | 39 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 98 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 298 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 115 | 0.030 |
Why?
|
| Body Composition | 1 | 2013 | 146 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2014 | 252 | 0.030 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 2 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2011 | 12 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 22 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 19 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 641 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 522 | 0.020 |
Why?
|
| Karyopherins | 1 | 2008 | 6 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 14 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 16 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2008 | 11 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 16 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 33 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 58 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 71 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 639 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 109 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 286 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 351 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 338 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 1289 | 0.020 |
Why?
|
| Mutation | 1 | 2008 | 1023 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2002 | 8 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 27 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 650 | 0.010 |
Why?
|